Perfil
Daniel Tesfa worked as a Medical Director at Swedish Orphan Biovitrum AB, Chief Medical Officer at Vivesto AB, and Country Medical Manager at Roche AB. He also worked as the Head of Oncology & Hematology at Bayer AB from 2018 to 2020.
Dr. Tesfa holds a doctorate degree from Karolinska Institutet and the University of Lund.
Antiguos cargos conocidos de Daniel Tesfa.
| Empresas | Cargo | Fin |
|---|---|---|
Bayer AB
Bayer AB Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Corporate Officer/Principal | 01/01/2020 |
Roche AB
Roche AB Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical goods | Corporate Officer/Principal | - |
| SWEDISH ORPHAN BIOVITRUM AB | Director Técnico/Científico/I+D | - |
| VIVESTO AB | Director Técnico/Científico/I+D | - |
Formación de Daniel Tesfa.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivesto AB
Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
Roche AB
Roche AB Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical goods | Health Technology |
Bayer AB
Bayer AB Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
- Bolsa de valores
- Insiders
- Daniel Tesfa
















